Literature DB >> 22101742

DUSP4 deficiency enhances CD25 expression and CD4+ T-cell proliferation without impeding T-cell development.

Ching-Yu Huang1, Yu-Chun Lin, Wan-Yi Hsiao, Fang-Hsuean Liao, Pau-Yi Huang, Tse-Hua Tan.   

Abstract

The differentiation and activation of T cells are critically modulated by MAP kinases, which are in turn feed-back regulated by dual-specificity phosphatases (DUSPs) to determine the duration and magnitude of MAP kinase activation. DUSP4 (also known as MKP2) is a MAP kinase-induced DUSP member that is dynamically expressed during thymocyte differentiation. We generated DUSP4-deficient mice to study the function of DUSP4 in T-cell development and activation. Our results show that thymocyte differentiation and activation-induced MAP kinase phosphorylation were comparable between DUSP4-deficient and WT mice. Interestingly, activated DUSP4(-/-) CD4(+) T cells were hyperproliferative while DUSP4(-/-) CD8(+) T cells proliferated normally. Further mechanistic studies suggested that the hyperproliferation of DUSP4(-/-) CD4(+) T cells resulted from enhanced CD25 expression and IL-2 signaling through increased STAT5 phosphorylation. Immunization of DUSP4(-/-) mice recapitulated the T-cell hyperproliferation phenotype in antigen recall responses, while the profile of Th1/Th2-polarized antibody production was not altered. Overall, these results suggest that other DUSPs may compensate for DUSP4 deficiency in T-cell development, MAP kinase regulation, and Th1/Th2-mediated antibody responses. More importantly, our data indicate that DUSP4 suppresses CD4(+) T-cell proliferation through novel regulations in STAT5 phosphorylation and IL-2 signaling.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101742      PMCID: PMC3517129          DOI: 10.1002/eji.201041295

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  40 in total

1.  Several dual specificity phosphatases coordinate to control the magnitude and duration of JNK activation in signaling response to oxidative stress.

Authors:  Chun-Hung Teng; Wen-Nin Huang; Tzu-Ching Meng
Journal:  J Biol Chem       Date:  2007-08-06       Impact factor: 5.157

Review 2.  The regulation of IL-10 production by immune cells.

Authors:  Margarida Saraiva; Anne O'Garra
Journal:  Nat Rev Immunol       Date:  2010-02-15       Impact factor: 53.106

3.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

4.  TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2.

Authors:  Sneha Ramesh; Xiao-Jun Qi; Gary M Wildey; Janet Robinson; Jeffery Molkentin; John Letterio; Philip H Howe
Journal:  EMBO Rep       Date:  2008-08-15       Impact factor: 8.807

Review 5.  T cell activation.

Authors:  Jennifer E Smith-Garvin; Gary A Koretzky; Martha S Jordan
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

6.  Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5.

Authors:  Wenbin Xiao; Hong Hong; Yuko Kawakami; Yuko Kato; Dianqing Wu; Hiroki Yasudo; Akiko Kimura; Hiromi Kubagawa; Luigi F Bertoli; Randall S Davis; Luan A Chau; Joaquin Madrenas; Cyrus C Hsia; Anargyros Xenocostas; Thomas J Kipps; Lothar Hennighausen; Atsushi Iwama; Hiromitsu Nakauchi; Toshiaki Kawakami
Journal:  Cancer Cell       Date:  2009-08-04       Impact factor: 31.743

7.  Cutting edge: selective tyrosine dephosphorylation of interferon-activated nuclear STAT5 by the VHR phosphatase.

Authors:  Richard Hoyt; Wei Zhu; Fabio Cerignoli; Andres Alonso; Tomas Mustelin; Michael David
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

8.  T-cell development and function are modulated by dual specificity phosphatase DUSP5.

Authors:  Panu E Kovanen; Jérôme Bernard; Amin Al-Shami; Chengyu Liu; Julie Bollenbacher-Reilley; Lynn Young; Cynthia Pise-Masison; Rosanne Spolski; Warren J Leonard
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

9.  Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse.

Authors:  Ching-Yu Huang; Andrea L Bredemeyer; Laura M Walker; Craig H Bassing; Barry P Sleckman
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

Review 10.  Interleukin-2 receptor signaling in regulatory T cell development and homeostasis.

Authors:  Matthew A Burchill; Jianying Yang; Kieng B Vang; Michael A Farrar
Journal:  Immunol Lett       Date:  2007-09-14       Impact factor: 3.685

View more
  30 in total

1.  Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling.

Authors:  E I Andersson; S Pützer; B Yadav; O Dufva; S Khan; L He; L Sellner; A Schrader; G Crispatzu; M Oleś; H Zhang; S Adnan-Awad; S Lagström; D Bellanger; J P Mpindi; S Eldfors; T Pemovska; P Pietarinen; A Lauhio; K Tomska; C Cuesta-Mateos; E Faber; S Koschmieder; T H Brümmendorf; S Kytölä; E-R Savolainen; T Siitonen; P Ellonen; O Kallioniemi; K Wennerberg; W Ding; M-H Stern; W Huber; S Anders; J Tang; T Aittokallio; T Zenz; M Herling; S Mustjoki
Journal:  Leukemia       Date:  2017-08-14       Impact factor: 11.528

2.  The phosphatase DUSP2 controls the activity of the transcription activator STAT3 and regulates TH17 differentiation.

Authors:  Dan Lu; Liang Liu; Xin Ji; Yanan Gao; Xi Chen; Yu Liu; Yang Liu; Xuyang Zhao; Yan Li; Yunqiao Li; Yan Jin; Yu Zhang; Michael A McNutt; Yuxin Yin
Journal:  Nat Immunol       Date:  2015-10-19       Impact factor: 25.606

3.  H3K27 Methylation Dynamics during CD4 T Cell Activation: Regulation of JAK/STAT and IL12RB2 Expression by JMJD3.

Authors:  Sarah A LaMere; Ryan C Thompson; Xiangzhi Meng; H Kiyomi Komori; Adam Mark; Daniel R Salomon
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

4.  Activation of PPARγ by endogenous prostaglandin J2 mediates the antileukemic effect of selenium in murine leukemia.

Authors:  Emily R Finch; Diwakar B Tukaramrao; Laura L Goodfield; Michael D Quickel; Robert F Paulson; K Sandeep Prabhu
Journal:  Blood       Date:  2017-01-23       Impact factor: 22.113

Review 5.  Dynamic Roles for IL-2-STAT5 Signaling in Effector and Regulatory CD4+ T Cell Populations.

Authors:  Devin M Jones; Kaitlin A Read; Kenneth J Oestreich
Journal:  J Immunol       Date:  2020-10-01       Impact factor: 5.422

6.  Single-Cell Transcriptomic Analysis of SARS-CoV-2 Reactive CD4 + T Cells.

Authors:  Benjamin J Meckiff; Ciro Ramírez-Suástegui; Vicente Fajardo; Serena J Chee; Anthony Kusnadi; Hayley Simon; Alba Grifoni; Emanuela Pelosi; Daniela Weiskopf; Alessandro Sette; Ferhat Ay; Grégory Seumois; Christian H Ottensmeier; Pandurangan Vijayanand
Journal:  SSRN       Date:  2020-07-07

Review 7.  Regulation of TCR signalling by tyrosine phosphatases: from immune homeostasis to autoimmunity.

Authors:  Stephanie M Stanford; Novella Rapini; Nunzio Bottini
Journal:  Immunology       Date:  2012-09       Impact factor: 7.397

Review 8.  Genomics of LGL leukemia and select other rare leukemia/lymphomas.

Authors:  Katharine B Moosic; Umadevi Paila; Kristine C Olson; Karolina Dziewulska; T Tiffany Wang; Jeffrey C Xing; Aakrosh Ratan; David J Feith; Thomas P Loughran; Thomas L Olson
Journal:  Best Pract Res Clin Haematol       Date:  2019-06-06       Impact factor: 3.020

9.  DUSP11 Attenuates Lipopolysaccharide-Induced Macrophage Activation by Targeting TAK1.

Authors:  Chia-Yu Yang; Huai-Chia Chuang; Ching-Yi Tsai; Yu-Zhi Xiao; Jhih-Yu Yang; Rou-Huei Huang; Ying-Chun Shih; Tse-Hua Tan
Journal:  J Immunol       Date:  2020-08-12       Impact factor: 5.422

10.  cAMP Response Element Modulator α Induces Dual Specificity Protein Phosphatase 4 to Promote Effector T Cells in Juvenile-Onset Lupus.

Authors:  Sigrun R Hofmann; Katrin Mäbert; Franz Kapplusch; Susanne Russ; Sarah Northey; Michael W Beresford; George C Tsokos; Christian M Hedrich
Journal:  J Immunol       Date:  2019-10-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.